Study identifies new target for treatment of pulmonary hypertension

April 30, 2018, Ann & Robert H. Lurie Children's Hospital of Chicago

Scientists at Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago have identified a gene called FoxM1 as a promising target for treatment of pulmonary hypertension, or high blood pressure in the lung arteries. Patients with this severe lung disease that damages the right side of the heart have a five-year survival rate of 50 percent. The study results, published in the American Journal of Respiratory and Critical Care Medicine, will drive development of new drugs to reverse a process called vascular remodeling, or thickening of lung artery walls - a key feature in pulmonary hypertension.

"Currently we do not have drugs that target vascular remodeling in ," says lead author Zhiyu Dai, PhD, from the Manne Research Institute at Lurie Children's, who also is a Research Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine. "Our study shows that when we deleted the FoxM1 gene in the of the artery in mice, the result was thinner , reduced blood pressure in the lung and improved right heart function. We can use a compound against FoxM1 to reverse vascular remodeling in rat models of the disease. "

FoxM1 gene controls cell growth and its function has been studied in cancer proliferation. Research on this gene is still in the preclinical stage. Dr. Dai and colleagues were the first to use a genetically modified mouse model to establish the role of FoxM1 in pulmonary hypertension. Without this gene in smooth muscle cells, the mouse does not grow thicker artery walls and so does not develop in the lung.

Dr. Dai and colleagues also discovered that in pulmonary hypertension, the FoxM1 gene is turned on by many growth factors that are released by damaged endothelial cells, which line the inner wall of the artery. Endothelial cell damage is considered to be the initial event in the development of pulmonary hypertension. Signals from the released growth factors induce FoxM1 gene expression to increase production of smooth muscle cells in the middle layer of the artery wall, which causes artery wall thickening.

"We will now focus on developing new drugs that will inhibit the FoxM1 gene and hopefully improve outcomes for patients with pulmonary hypertension," says Dr. Dai.

Explore further: Crosstalk between cells plays role in pulmonary hypertension

Related Stories

Crosstalk between cells plays role in pulmonary hypertension

April 25, 2018
Pulmonary hypertension is a type of high blood pressure that affects blood vessels in the lungs. Once diagnosed, patients have limited treatment options, and many do not live beyond seven years. In a new study, scientists ...

Pulmonary artery stiffening is an early driver of pulmonary hypertension

June 2, 2016
Pulmonary hypertension is an abnormal elevation of pressure in the pulmonary circulation that results in stress on the heart and remodeling of blood vessels in the lung. Pulmonary hypertension is caused by a variety of factors, ...

New targets for treating pulmonary hypertension found

September 8, 2014
Two new potential therapeutic targets for the treatment of pulmonary arterial hypertension, a deadly disease marked by high blood pressure in the lungs, have been identified by researchers at the University of Illinois at ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Study identifies new molecular target for treating deadly lung disease IPF

April 10, 2018
Scientists searching for a therapy to stop the deadly and mostly untreatable lung disease, idiopathic pulmonary fibrosis (IPF), found a new molecular target that slows or stops the illness in preclinical laboratory tests.

Johns Hopkins investigators unravel biological roots of pulmonary hypertension

March 27, 2018
Working with cells that line the innermost layer of the blood vessels, Johns Hopkins investigators say they have made a leap forward in understanding the underlying biology behind pulmonary hypertension, a dangerous type ...

Recommended for you

To have or not to have... your left atrial appendage closed

May 22, 2018
Each year in the U.S., more than 300,000 people have heart surgery. To reduce risk of stroke for their patients, surgeons often will close the left atrial appendage, which is a small sac in the left side of the heart where ...

Natural antioxidant bilirubin may improve cardiovascular health

May 18, 2018
Bilirubin, a yellow-orange pigment, is formed after the breakdown of red blood cells and is eliminated by the liver. It's not only a sign of a bruise, it may provide cardiovascular benefits, according to a large-scale epidemiology ...

New algorithm more accurately predicts life expectancy after heart failure

May 17, 2018
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more ...

New genes found that determine how the heart responds to exercise

May 17, 2018
A new study by researchers at Queen Mary University of London and University College London (UCL) has discovered 30 new gene locations that determine how the heart responds to and recovers from exercise.

Novel therapy inhibits complement to preserve neurons and reduce inflammation after stroke

May 16, 2018
A team of investigators at the Medical University of South Carolina (MUSC) has developed a novel therapy for ischemic (clot-caused) stroke and has shown in a preclinical model that it locally inhibits complement at and around ...

Greater burden of atrial fibrillation linked to higher stroke risk

May 16, 2018
Among people with intermittently recurring atrial fibrillation who are not taking anti-blood-clotting medications, those whose hearts were in abnormal rhythms longer were three times more likely to have strokes or other types ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.